首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   684篇
  免费   75篇
  国内免费   14篇
耳鼻咽喉   3篇
儿科学   12篇
妇产科学   18篇
基础医学   36篇
口腔科学   6篇
临床医学   205篇
内科学   40篇
皮肤病学   4篇
神经病学   25篇
特种医学   5篇
外科学   29篇
综合类   150篇
一般理论   2篇
预防医学   135篇
药学   57篇
中国医学   39篇
肿瘤学   7篇
  2024年   6篇
  2023年   16篇
  2022年   16篇
  2021年   26篇
  2020年   28篇
  2019年   30篇
  2018年   34篇
  2017年   21篇
  2016年   15篇
  2015年   26篇
  2014年   40篇
  2013年   58篇
  2012年   32篇
  2011年   26篇
  2010年   22篇
  2009年   27篇
  2008年   35篇
  2007年   34篇
  2006年   45篇
  2005年   39篇
  2004年   37篇
  2003年   30篇
  2002年   21篇
  2001年   26篇
  2000年   11篇
  1999年   13篇
  1998年   10篇
  1997年   15篇
  1996年   5篇
  1995年   4篇
  1994年   10篇
  1993年   1篇
  1992年   5篇
  1991年   2篇
  1990年   1篇
  1989年   2篇
  1986年   1篇
  1985年   1篇
  1984年   1篇
  1980年   1篇
排序方式: 共有773条查询结果,搜索用时 15 毫秒
81.
AIMS: To compare issues raised by Human Research Ethics Committees (HREC) during the ethics review process and to determine the length of time taken to gain HREC approval for multicentre research studies. METHODS: Review and analysis of HREC documentation and correspondence for all multicentre research studies were conducted through three HREC under the auspices of Cancer Trials Australia, Melbourne, Victoria, Australia, between November 1997 and March 2001 to determine the variance of documentation, correspondence and recommendations across the three HREC and the time taken for study approval. RESULTS: Thirty-one projects were submitted to any two of the HREC (16 studies) or all three HREC (15 studies). The median time for study approval at an individual HREC was 75 days, but it was 111 days for approval at all participating sites. There were 554 clarifications or comments made by the reviewing HREC, the majority of which had no significant bearing on the ethical or scientific calibre of the study. There was only one study in which a significant protocol change was requested by a HREC. CONCLUSIONS: Multicentre study approvals are delayed when submitted to multiple HREC. The three HREC raised similar issues without substantive differences in their recommendations. A process for the mutual acceptance of HREC recommendations could facilitate multicentre research.  相似文献   
82.
FDA于2018年6月25日批准Epidiolex口服溶液用于治疗难治性癫痫,其活性成分是来源于大麻的高纯度原料大麻二酚。本文通过对FDA关于Epidiolex的审评过程进行分析,结合其审评制度探索FDA在人用经验、化学制造和控制(chemistry,manufacturing,and control,CMC)、非临床、临床等方面的审评思路。同时对FDA关于植物来源高纯度药物审评的重点及特点进行阐述,目的是为我国天然药物研究和技术审评提供有益的参考。  相似文献   
83.
目的探讨医务人员道德推脱与道德决策的关系以及组织承诺在两者之间的调节作用。方法采用整群抽样的方法对江西省5所三甲医院的286名医务人员进行问卷调查,采用SPSS 16.0进行数据分析。结果医务人员道德推脱、道德识别、道德判断、道德意图、组织承诺平均分分别为(88.10±16.78)、(18.53±3.47)、(13.47±3.58)、(30.43±9.95)、(67.28±8.57)分;不同学历的医务人员道德推脱、道德判断得分差异均有统计学意义(P<0.05),不同年龄医务人员道德识别、道德判断得分差异均有统计学意义(P<0.05);医务人员道德推脱与道德识别呈负相关(r=-0.349,P<0.05),与道德判断和道德意图均呈正相关(r=0.301、0.211,P<0.01);组织承诺对道德推脱和道德识别之间的关系产生显著的调节作用,对道德判断和道德意图产生直接作用。结论医务人员道德推脱与道德决策存在显著相关,组织承诺在道德推脱与道德识别关系中存在调节作用。  相似文献   
84.
我国卫生改革的医学道德意义和伦理原则   总被引:3,自引:2,他引:1  
在我国卫生改革全面展开的基础上,探讨了卫生改革具有的医学道德意义,并提出了卫生改革应遵循的伦理原则,其目的在于推进卫生改革的深化和健康发展。  相似文献   
85.
The charge of this Section is ethics and global responsibilities in oral health and disease. Oral health is determined by the same factors as those for general health. To a limited extent, the level of oral health care and dental education. The philosophy and organization of the health care system and dental education, therefore, are key determinants of oral health. Dental education has expanded in many countries where there has been an increase in wealth. Unfortunately, there has been no concomitant increase in the number of dental educators. This is a problem throughout the world. This present situation raises certain ethical issues with regard to professional responsibilities. It also raises some important questions for dental education. This Section has chosen to focus its efforts on examining two issues:
  • • What can be done within dental schools?

      相似文献   
86.
87.
Despite enjoying a higher level of safety from many dangers than that experienced in any previous historical epoch, there is widespread public concern in the world's richer societies over a series of other threats and risks. This paper focuses on the problem of personal violence and the development of a body of research designed to inform assessment of its likelihood in individual cases. The paper provides an overview of the evidence from research in both mental health and criminal justice supporting the general validity of risk assessment, and an account of some of the obstacles that arise when such procedures are implemented in practice. This overview is followed by consideration of a series of ethical conflicts emerging from the use of risk assessment procedures; and an outline of some current proposals and other possible departures that may contribute to their resolution.  相似文献   
88.
The process of sloving an ethical dilemma is presented through use of a case study involiving a dishonest doctor and a cancer patient. The described decision making process contributes to compliance with the Joint Commission on Accreditation of Healthcare Organization standard regarding ethics and patient care. Curtin's ethical decision-making framework is employed in this described process. Ethical principles and philosophies are considered in attempting to find the best ethical solution for the dilemma detailed in the case study.
Source material is from personal experience and observation as well as published literature. In addition to being a JCAHO standard, the author concludes that a decision-making framework is useful in solving ethical dilemmas.  相似文献   
89.
Development of live donor kidney transplantation (LDKT) programs has intensified debate regarding acceptability of certain donor categories and potential commercialization. Concerning these issues, we surveyed the views of medical and nursing staff caring for patients with renal failure and renal transplant recipients and donors. Participants were recruited from a tertiary transplant unit and invited to complete an anonymous questionnaire. Four hundred and sixty-four participants completed the questionnaire (42% response). One hundred and sixty-eight (36.2%) were health care professionals and 296 (63.8%) patients; 85.6% of participants were willing to donate to their children, 80.2% to siblings, 80.8% to parents, 72% to a non-blood-related relative or friend, and 15.3% to a stranger. If participants had hypothetical renal failure, they were prepared to accept a kidney from a parent (79.5%), sibling (78.7%), child (56.3%), a non-blood-related relative or friend (79.3%), or stranger (54.1%). Regarding commercialization, responders' attitudes were that the donor should not accept financial reward (29.1%), be compensated for expenses only (60.6%), or should receive a direct financial reward (10.1%). For non-directed donation, 23.5%, 55.6%, and 20.7% were not in support of reward, compensation only, and financial reward, respectively. While live kidney donation was accepted by the majority of individuals surveyed, only the minority approved of commercialization.  相似文献   
90.
In recent years a growing body of evidence has highlighted the impact of neuroleptics and antidepressants on sexual function. Research from a service user's perspective suggested that service users are dissatisfied with the information that they received on drugs, and would like more education, in particular, on the side effects of medication that impact on sexual function. This paper reports some of the findings of a grounded theory study that explored how psychiatric nurses responded to issues of sexuality in practice. Emphasis within the paper is given to how nursing staff addressed the side effects of drugs that impact on sexual function. Findings suggested that nurse addressed the issue of prescribed medication and sexual function in practice, using a 'Veiling Sexualities Cycle', which had three subcategories: 'Hanging the Veil', 'Lifting the Veil' and 'Re-veiling'. In the light of contemporary mental health policy, findings from the study are discussed and recommendations for practice and education made.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号